Be. Slack et al., REGULATION BY PHORBOL ESTERS OF AMYLOID PRECURSOR PROTEIN RELEASE FROM SWISS 3T3 FIBROBLASTS OVEREXPRESSING PROTEIN KINASE-C-ALPHA, The Journal of biological chemistry, 268(28), 1993, pp. 21097-21101
Release of large soluble NH2-terminal fragments of the amyloid precurs
or protein (APP) of Alzheimer's disease was measured in two Swiss 3T3
fibroblast cell lines (designated SF1.4 and SF3.2), overexpressing the
alpha subtype of protein kinase C, and in two control cell lines (SC1
and SC2) (Eldar, H., Zisman, Y., Ullrich, A., and Livneh, E. (1990) J
. Biol. Chem. 265, 13290-13296). Basal release of APP was significantl
y increased in SF1.4 cells, but not in SF3.2 cells, relative to contro
ls. Phorbol 12-myristate 13-acetate, an activator of protein kinase C,
elicited a concentration-dependent increase in APP release in all fou
r cell lines. However, the estimated EC50 for this effect was lower in
the two cell lines overexpressing protein kinase C-alpha (7 and 6 nM,
in SF1.4 and SF3.2 cells, respectively) than in control SC1 and SC2 c
ells (56 and 22 nM, respectively). The absolute amount of APP released
by maximal concentrations of phorbol ester was not altered by overexp
ression of protein kinase Calpha. The protein kinase C inhibitor H-7 (
1-(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride) signifi
cantly reduced the response to phorbol esters in control (SC1) cells b
ut not in cells (SF1.4) that overexpress protein kinase Calpha. Levels
of cell-associated APP were slightly elevated, and rates of APP turno
ver were unchanged, in SF1.4 cells relative to controls. However, cell
-associated APP levels were lower in SF3.2 cells than in controls. The
results demonstrate that protein kinase Calpha regulates APP release
in Swiss 3T3 fibroblasts, and perhaps in other tissues, including brai
n, and may be the isozyme that mediates receptor-evoked release of APP
.